Compare CBIO & VFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CBIO | VFF |
|---|---|---|
| Founded | 2003 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 389.7M | 396.2M |
| IPO Year | N/A | N/A |
| Metric | CBIO | VFF |
|---|---|---|
| Price | $10.83 | $3.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $27.17 | N/A |
| AVG Volume (30 Days) | 142.5K | ★ 1.1M |
| Earning Date | 02-23-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $351,979,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.43 |
| P/E Ratio | ★ N/A | $17.89 |
| Revenue Growth | N/A | ★ 56.61 |
| 52 Week Low | $9.81 | $0.45 |
| 52 Week High | $21.40 | $4.99 |
| Indicator | CBIO | VFF |
|---|---|---|
| Relative Strength Index (RSI) | 37.86 | 43.80 |
| Support Level | $10.56 | $3.25 |
| Resistance Level | $14.71 | $3.65 |
| Average True Range (ATR) | 1.01 | 0.17 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 6.14 | 38.75 |
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.